By Dirk Brinckman Chief Compliance Officer, Johnson & Johnson Chair, IFPMA Ethics and Business Integrity Committee Chair, ...
IFPMA submitted a statement at the start of the 17th meeting of the Conference of the Parties to the Convention on Biological ...
On 13 October 2026, on the occasion of the adoption of the Political Declaration on Pandemic Prevention, Preparedness, and ...
This infographic shows how just a 1% increase in seasonal influenza vaccination coverage can deliver substantial health and economic benefits. It highlights influenza’s global disease burden, ...
Governments around the world are confronting increasingly common challenges: how to drive economic growth, address demographic changes and productivity pressures, and how to strengthen national ...
On 25 September 2026 in New York City, IFPMA delivered a statement at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response. Panel 1: Multilateral action for coordinated ...
Consideration of the Political Declaration on Pandemic Prevention, Preparedness, and Response (PPPR)
On the occasion of the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response, Dr. David Reddy, Director General, IFPMA, said: “The global pharmaceutical industry urges governments ...
Longer life expectancy is one of the greatest successes of the last century. Since the 1960s alone, people in the European Union have gained, on average, more than two additional years of life per ...
As world leaders gather at the United Nations to agree on a Political Declaration on Pandemic Prevention, Preparedness, and Response (PPPR), the global pharmaceutical industry is urging governments to ...
On 29 September 2026 in Washington, D.C., IFPMA delivered a statement on the strategy for strengthening health emergency and risk management for health security 2026-2031 at the 63rd Directing Council ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results